Evidence map›Paper›PMID 35634388›Full record

ArticleFrontiers in nutrition2022

Acidic Activated Charcoal Prevents Obesity and Insulin Resistance in High-Fat Diet-Fed Mice.

Xuguang Zhang, Pan Diao, Hiroaki Yokoyama, Yoshiki Inoue, Kazuhiro Tanabe, Xiaojing Wang, Chihiro Hayashi, Tomoki Yokoyama, Zhe Zhang, Xiao Hu and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Xuguang ZhangDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Pan DiaoDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Hiroaki YokoyamaSumi Plus Lab Co., Ltd., Yokohama, Japan.
Yoshiki InoueIna Carbonization Laboratory Co., Ltd., Ina, Japan.
Kazuhiro TanabeMedical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, Tokyo, Japan.
Xiaojing WangDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Chihiro HayashiMedical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, Tokyo, Japan.
Tomoki YokoyamaSumi Plus Lab Co., Ltd., Yokohama, Japan.
Zhe ZhangDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Xiao HuDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Takero NakajimaDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Takefumi KimuraDepartment of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.
Jun NakayamaDepartment of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
Makoto NakamutaDepartment of Gastroenterology, Kyushu Medical Center, Fukuoka, Japan.
Naoki TanakaDepartment of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
Shinshu University · JPHebei Medical University · CNNational Kyushu Medical Center · JPZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is becoming a major public health problem worldwide. Making charcoal from wood ("Sumi-yaki") has been a traditional activity in the southern part of Nagano Prefecture for centuries, with activated charcoal having reported detoxifying effects. However, it is unclear whether activated charcoal also possesses anti-obesity properties. Additionally, since activated charcoal is usually alkaline and might be affected by gastric juice, we evaluated the effect of acidic activated charcoal on high-fat diet (HFD)-induced obesity. This study demonstrated that co-treatment of acidic activated charcoal with a HFD significantly improved obesity and insulin resistance in mice in a dose-dependent manner. Metabolomic analysis of cecal contents revealed that neutral lipids, cholesterol, and bile acids were excreted at markedly higher levels in feces with charcoal treatment. Moreover, the hepatic expressions of genes encoding cholesterol 7 alpha-hydroxylase and hydroxymethylglutaryl-CoA reductase/synthase 1 were up-regulated by activated charcoal, likely reflecting the enhanced excretions from the intestine and the enterohepatic circulation of cholesterol and bile acids. No damage or abnormalities were detected in the gastrointestinal tract, liver, pancreas, and lung. In conclusion, acidic activated charcoal may be able to attenuate HFD-induced weight gain and insulin resistance without serious adverse effects. These findings indicate a novel function of charcoal to prevent obesity, metabolic syndrome, and related diseases.

Indexed as

acidic activated charcoalbile acidenterohepatic circulationinsulin resistanceintestinemetabolic syndromemetabolomic analysisobesity

Identifiers

PMID35634388
PMCPMC9134190
OpenAlexW4280619442

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.